Glucagon-Like Peptide-1 Receptor Agonist-Associated Hepatotoxicity

Melissa Palmer

Open source

DOI
10.1016/j.clinthera.2026.09.002
Published
2026-09
Container
Clinical Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clinthera.2026.09.002,
  title = {Glucagon-Like Peptide-1 Receptor Agonist-Associated Hepatotoxicity},
  author = {Melissa Palmer},
  year = {2026},
  journal = {Clinical Therapeutics},
  doi = {10.1016/j.clinthera.2026.09.002},
  url = {https://doi.org/10.1016/j.clinthera.2026.09.002}
}

RIS

TY  - JOUR
TI  - Glucagon-Like Peptide-1 Receptor Agonist-Associated Hepatotoxicity
AU  - Melissa Palmer
PY  - 2026
JO  - Clinical Therapeutics
DO  - 10.1016/j.clinthera.2026.09.002
UR  - https://doi.org/10.1016/j.clinthera.2026.09.002
ER  - 

APA

Palmer, M. (2026). Glucagon-Like Peptide-1 Receptor Agonist-Associated Hepatotoxicity. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2026.09.002

Source records